logo

Takeda Pharma (TAK)



Trade TAK now with
  Date
  Headline
7/22/2019 1:18:22 AM Takeda Announces Top-line Results From VISIBLE 2 Clinical Trial
7/8/2019 2:24:01 AM Takeda Reports Updated Results From Phase IIIb/IV Clinical Trial For ADYNOVATE
6/3/2019 7:32:10 AM Takeda Announces New Data From An Ad-hoc Analysis Of Phase 3 HELP Study
5/14/2019 2:30:36 AM Takeda FY Consolidated Reported Revenue Up 18.5% To 2.097 Trln Yen
3/18/2019 8:05:33 AM Takeda Gets FDA Approval To Manufacture FLEXBUMIN At New Plasma Manufacturing Facility Near Covington, Georgia
2/6/2019 1:14:09 AM Takeda Announces Results From First-of-Its-Kind Phase IIIb/IV Trial PROPEL
2/1/2019 1:26:14 AM Takeda Pharma 9-month EPS 210 Yen Vs 309 Yen Last Year
1/10/2019 7:04:44 AM Takeda In Canada Headed By General Manager Gamze Yüceland
1/3/2019 8:23:53 AM Takeda Notes Court Sanction Of Scheme Of Arrangement With Respect To Acquisition Of Shire Plc
12/19/2018 2:38:41 AM Takeda Announces Listing Of ADSs On NYSE Under Symbol "TAK"
12/5/2018 9:35:30 AM Shire Reports Requisite Majority At Court Meeting And General Meeting
12/5/2018 12:39:27 AM Takeda Shareholders Approve Resolutions Related To Proposed Shire Deal
12/2/2018 10:50:29 AM Takeda To Present Positive Data From TOURMALINE-MM3
11/27/2018 8:11:17 AM Takeda Says EU Oks ALUNBRIG For ALK+ Non-Small Cell Lung Cancer In Patients Previously Treated With Crizotinib
11/12/2018 2:42:13 AM Takeda Reports Publication Of Notice Of Extraordinary General Meeting Of Shareholders Regarding Shire Deal